Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Diamyd Medical | interview with CEO Ulf Hannelius
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Diamyd Medical | interview with CEO Ulf Hannelius
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:00:00
Stephanie Unwin, CEO, Phylogica Ltd
00:10:00
Victaulic's Pioneering Innovations in Piping Systems
00:10:00
Barbara Wittmann, Co-Managing Director of LinkedIn, along with the CEO and co-owner of Cura Marketing GmbH, Judith, are associated with Fabasoft AG.
00:10:00
Brandon Leyert on Market Trends, Sector Hotspots, and Economic Outlook for 2011
00:10:00
URA Holdings CEO Bernard Olivier Provides Operational Update on Gravelotte Emerald Mine | Dr. Bernard Olivier ,CEO ,URA Holdings Plc.
00:10:00
Jeremy Smouha and Edward Bonham Carter's discussion on investment topics, including bonds, equities, and macroeconomic trends.
00:10:00
Radio frequencies are being used in a trial project in Alberta to heat the oil sands and reduce pollution | GEOFF CLARK, Chief Executive Officer, Acceleware Ltd AXE:CVE
00:10:00
Bloom Energy Corp. CEO K.R. Sridhar discusses the ascendancy of clean energy and its implications amid PG&E's bankruptcy fallout.|KR Sridhar,is the PhD Founder, Chairman and Chief Executive Officer of Bloom Energy Corp.
00:10:00
Breaking Barriers and Building Generational Wealth | Martin Cabrera Jr. - Chief Executive Officer of Cabrera Capital Markets
00:00:00
Eden Research 'well positioned to growth consistently' -Sean Smith, CEO, Eden Research
00:10:00
Nicholas Eberstadt on Political Economy and 'Men Without Work|Nicholas Eberstadt,Professor,American Enterprise Institute
00:10:00
Valor Resources (ASX: VAL) is progressing its Canadian uranium projects, as highlighted by executive chairman George Bauk during an interview with Wally Graham of The Resources Roadhouse at the RIU Resurgence 2023 Conference in Perth.|GEORGE BAUK, EXECUTI